...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Top-Line Primary Endpoint Results for Phase 3 BETonMACE Cardio Outcomes Trial were Announced September 30th ****Detailed Trial Data to be Presented at AHA Late Breaking Session Nov 16th & Company Webcast Nov 18th******

Message: 3 ASN Kidney Conference Presentations Nov 8-9

Tada, thanks for bringing up the diabetes aspect. It will be very interesting to find out next Saturday if there was any beneficial effect of apabetalone in fasting glucose, fasting insulin and HbA1c. As you suggested, maybe a synergy with a current diabetes drug like metformin, or maybe apabetalone across the board improved glucose/insulin/HbA1c over placebo. I wrote a bit on The Glucose Effect earlier this year.


New Message
Please login to post a reply